{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:16:03Z","timestamp":1762492563416,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ijcha.2021.100779","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T14:02:42Z","timestamp":1619445762000},"page":"100779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3183-5660","authenticated-orcid":false,"given":"Nobuhiro","family":"Nishii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifusa","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5092-1893","authenticated-orcid":false,"given":"Tohru","family":"Ohe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2983-0732","authenticated-orcid":false,"given":"Takashi","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijcha.2021.100779_b0005","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"I.I.I. Multicenter automatic defibrillator implantation trial, prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ijcha.2021.100779_b0010","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcha.2021.100779_b0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ijcha.2021.100779_b0020","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.ijcha.2021.100779_b0025","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2007.09.073","article-title":"Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact","volume":"51","author":"Daubert","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcha.2021.100779_b0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.joa.2015.10.002","article-title":"Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator","volume":"32","author":"Rahmawati","year":"2016","journal-title":"J. Arrhythm."},{"issue":"5","key":"10.1016\/j.ijcha.2021.100779_b0035","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.hrthm.2017.12.026","article-title":"Defibrillator shocks and their effect on objective and subjective patient outcomes: results of the PainFree SST clinical trial","volume":"15","author":"Sears","year":"2018","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.ijcha.2021.100779_b0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jacc.2008.05.011","article-title":"Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study","volume":"52","author":"Wilkoff","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"24","key":"10.1016\/j.ijcha.2021.100779_b0045","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijcha.2021.100779_b0050","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.hrthm.2015.01.017","article-title":"Low inappropriate shock rates in patients with single- and dual\/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results","volume":"12","author":"Auricchio","year":"2015","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.ijcha.2021.100779_b0055","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/ijcp.12033","article-title":"Lower incidence of inappropriate shock therapy in patients with combined cardiac resynchronisation therapy defibrillators (CRT-D) compared with patients with non-CRT defibrillators (ICDs)","volume":"67","author":"Chen","year":"2013","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"10.1016\/j.ijcha.2021.100779_b0060","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.114.001965","article-title":"Novel ICD programming and inappropriate ICD therapy in CRT-D versus ICD patients: a MADIT-RIT sub-study","volume":"9","author":"Kutyifa","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"8","key":"10.1016\/j.ijcha.2021.100779_b0065","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jce.12692","article-title":"Reduction in inappropriate ICD therapy in MADIT-RIT patients without history of atrial tachyarrhythmia","volume":"26","author":"Kutyifa","year":"2015","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"4","key":"10.1016\/j.ijcha.2021.100779_b0070","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.hrthm.2015.12.032","article-title":"Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy)","volume":"13","author":"Biton","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ijcha.2021.100779_b0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2017.11.077","article-title":"Significant impact of electrical storm on mortality in patients with structural heart disease and an implantable cardiac defibrillator","volume":"255","author":"Noda","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcha.2021.100779_b0080","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1253\/circj.CJ-14-0589","article-title":"Appropriate duration of driving restrictions after inappropriate therapy from implantable cardiac shock devices-interim analysis of the Nippon Storm Study","volume":"78","author":"Noda","year":"2014","journal-title":"Circ. J."},{"issue":"2","key":"10.1016\/j.ijcha.2021.100779_b0085","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.hrthm.2015.11.018","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"13","author":"Wilkoff","year":"2016","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.ijcha.2021.100779_b0090","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1460-9592.2001.01061.x","article-title":"Prospective evaluation of catheter ablation in patients with implantable cardioverter defibrillators and multiple inappropriate ICD therapies due to atrial fibrillation and type I atrial flutter","volume":"24","author":"Korte","year":"2001","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"2","key":"10.1016\/j.ijcha.2021.100779_b0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/europace\/euu185","article-title":"Catheter ablation of atrial tachyarrhythmias causing inappropriate implantable cardioverter-defibrillator shocks","volume":"17","author":"Miyazaki","year":"2015","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.ijcha.2021.100779_b0105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/eurheartj\/ehs425","article-title":"A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial","volume":"34","author":"Guedon-Moreau","year":"2013","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcha.2021.100779_b0110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/jce.13399","article-title":"Analysis of arrhythmic events is useful to detect lead failure earlier in patients followed by remote monitoring","volume":"29","author":"Nishii","year":"2018","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"16","key":"10.1016\/j.ijcha.2021.100779_b0115","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jacc.2011.07.020","article-title":"Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)","volume":"58","author":"Brenyo","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcha.2021.100779_b0120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1161\/CIRCULATIONAHA.110.955039","article-title":"Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy","volume":"122","author":"Solomon","year":"2010","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcha.2021.100779_b0125","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jacc.2007.04.073","article-title":"Improvement of atrial function and atrial reverse remodeling after cardiac resynchronization therapy for heart failure","volume":"50","author":"Yu","year":"2007","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906721000671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906721000671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:11:14Z","timestamp":1762492274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906721000671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":24,"alternative-id":["S2352906721000671"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2021.100779","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2021.100779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100779"}}